Keyphrases
Mouse Model
100%
In Vivo Evaluation
100%
Prostate Carcinoma
100%
Bombesin
100%
Bombesin Analogues
100%
GRP Receptor
33%
PC-3 Cells
25%
Metabolic Stability
25%
Prostate Cancer
16%
Positron Emission Tomography
16%
125I
16%
Pharmacokinetics
8%
Tumor
8%
Clinical Translation
8%
Liver
8%
Tumor Targeting
8%
Prostate Radiotherapy
8%
Overexpression
8%
Prostate Cancer Cells
8%
Kidney
8%
Prostate Cancer Screening
8%
Cell Surface
8%
In Vivo Pharmacokinetics
8%
High Affinity
8%
High-performance Liquid Chromatography
8%
High Specificity
8%
Nude Mice
8%
50% Inhibitory Concentration
8%
PC-3
8%
Receptor Affinity
8%
Human Prostate Tissue
8%
22Rv1
8%
Competitive Binding Assay
8%
Radioligand
8%
Pro-gastrin-releasing Peptide (ProGRP)
8%
Gastrin-releasing Peptide Receptor (GRPr)
8%
Targeting Efficacy
8%
Systemic Distribution
8%
MicroPET Imaging
8%
Tumor Contrast
8%
Androgen-independent
8%
Tumor Activity
8%
Medicine and Dentistry
In Vitro
100%
Prostate Adenocarcinoma
100%
Copper 64
100%
Bombesin
100%
Tetraxetan
71%
Receptor
42%
Radioactive Tracer
28%
Prostate Cancer
21%
Neoplasm
21%
Positron Emission Tomography
14%
Pharmacokinetics
14%
Iodine 125
14%
Cancer Therapy
7%
Cancer Cell
7%
Receptor Affinity
7%
Cell Surface
7%
Prostate Tissue
7%
High-Performance Liquid Chromatography
7%
Kidney Tumour
7%
Radioligand
7%
Competitive Binding Assay
7%
Gastrin-Releasing Peptide
7%
Prostate Cancer Diagnosis
7%
Liver Tumor
7%
Gastrin Releasing Peptide Receptor
7%
IC50
7%
Androgen
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Prostate Adenocarcinoma
100%
Copper 64
100%
Bombesin
100%
Tetraxetan
71%
Receptor
50%
Prostate Cancer
28%
Tracer
28%
Neoplasm
21%
Iodine-125
14%
Pharmacokinetics
14%
High Performance Liquid Chromatography
7%
Nude Mouse
7%
Radioligand
7%
Gastrin Releasing Peptide
7%
Gastrin Releasing Peptide Receptor
7%
IC50
7%
Androgen
7%
Liver Tumor
7%
Kidney Tumour
7%
Immunology and Microbiology
Mouse Model
100%
Prostate
100%
Bombesin
100%
Iodine-125
14%
Positron Emission Tomography
14%
Pharmacokinetics
14%
Gastrin Releasing Peptide
14%
High Performance Liquid Chromatography
7%
Receptor Affinity
7%
Cancer Cell
7%
Cell Surface
7%
Prostate Tissue
7%
Nude Mouse
7%
IC50
7%
Binding Competition
7%
Homogenate
7%
Peptide Receptor
7%